A Phase I Study of ECO-4601 in Patients With Advanced Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Tumors|Glioma|Colorectal Cancer|Lung Cancer|Breast Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer
Interventions: DRUG: ECO-4601
Sponsor: Thallion Pharmaceuticals